![](/img/cover-not-exists.png)
109PSequential administration of EGFR-TKI and pemetrexed achieved a long period of response in advanced NSCLC patients with EGFR-mutant tumors
Chen, Y-Y., Zhu, Q-Q., Dai, L-J., Ding, Z-Y.Volume:
28
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx091.029
Date:
April, 2017
File:
PDF, 88 KB
2017